EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study

Rehab M Abdel-Megeed iD, Hassan Z Ghanem iD, Mai O Kadry

Therapeutic Delivery · 2024

DOI: 10.4155/tde-2023-0121 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Therapeutic Delivery, 2024. Verfasst von Rehab M Abdel-Megeed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, …. Hauptthemen laut MEDLINE: Doxorubicin, Polyethylene Glycols, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Drug resistance is still a significant barrier to effective hepatocellular carcinoma therapy. Address the issue of doxorubicin resistance and inter-receptor crosstalk various doxorubicin formulations were investigated.

Methods

Hepatocellular carcinoma was carried out using 3-methylechloroanthrene. Animals were then treated with doxorubicin, liposomal doxorubicin, titanium-loaded doxorubicin (TiO2-Dox), lactoferrin-doxorubicin and PEGylated doxorubicin. Biochemical and molecular analyses were assessed.

Results

Results have declared a significant alternation of both sodium and potassium concentrations upon 3-methylechloroanthrene administration. Arginase-I and α-L-Fucodinase tumor biomarkers were significantly elevated. C-myc, Hprt-1 and EGFR gene expression were over-expressed. Treatment with the aforementioned treatment regimens significantly modulated all measured parameters.

Conclusion

TiO2-Dox, doxorubicin-lactoferrin and PEGylated doxorubicin could be a promising regimen in hepatocellular carcinoma and overcoming the problem of drug resistance. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPolyethylene GlycolsCarcinoma, HepatocellularAnimalsDrug Delivery SystemsAntibiotics, AntineoplasticTitaniumLactoferrinDrug Resistance, NeoplasmLiver NeoplasmsMaleHumansBiomarkers, Tumor

Stichwörter der Autor:innen

C-mycEGFRHbrt-1Hepatocellular carcinomaPEGylated doxorubicinlactoferrin-doxorubicintitanium dioxide-loaded doxorubicin

Substanzen

DoxorubicinPolyethylene GlycolsAntibiotics, AntineoplasticTitaniumLactoferrinliposomal doxorubicintitanium dioxideBiomarkers, Tumor

Autor:innen und Institutionen

  • Therapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt.

ORCID-Profile: Rehab M Abdel-Megeed, Hassan Z Ghanem

Förderung

  • National Research Centre

Zitieren

APA

Abdel-Megeed, R. M., Ghanem, H. Z., & Kadry, M. O. (2024). Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study. Therapeutic Delivery. https://doi.org/10.4155/tde-2023-0121

Vancouver

Abdel-Megeed RM, Ghanem HZ, Kadry MO. Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study. Therapeutic Delivery. 2024. doi:10.4155/tde-2023-0121

BibTeX
@article{AbdelMegeed2024,
  author = {Abdel-Megeed, Rehab M and Ghanem, Hassan Z and Kadry, Mai O},
  title = {Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study},
  journal = {Therapeutic Delivery},
  year = {2024},
  doi = {10.4155/tde-2023-0121}
}
Kostenlos starten →